Nightingale Health Oyj
OMXH:HEALTH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.994
4.11
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nightingale Health Oyj
Depreciation & Amortization
Nightingale Health Oyj
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
Nightingale Health Oyj
OMXH:HEALTH
|
Depreciation & Amortization
€8.2m
|
CAGR 3-Years
49%
|
CAGR 5-Years
105%
|
CAGR 10-Years
N/A
|
|
|
T
|
Terveystalo Oyj
OMXH:TTALO
|
Depreciation & Amortization
€189.8m
|
CAGR 3-Years
29%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pihlajalinna Oyj
OMXH:PIHLIS
|
Depreciation & Amortization
€54.2m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nightingale Health Oyj
Glance View
Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. The company is headquartered in Helsinki, Etela-Suomen and currently employs 77 full-time employees. The company went IPO on 2021-03-19. The blood analysis technology developed by Nightingale measures a broad group of biomarkers from a single blood sample, recognizing individual disease risks. The firm provides people with comprehensive insights on health, helps them make better decisions regarding their health and connects them with healthcare experts that offer preventative services for maintaining health. Nightingale Health Oy is the Parent Company in the Nightingale Group. The Group comprises the parent Company’s subsidiaries: Nightingale Health United States Inc, Nightingale Health Asia Pte Ltd, Nightingale Health Japan KK as well as NG Health Sweden AB. The firm owns and independently oversees two laboratories in Finland, in Helsinki and Kuopio, and one laboratory in Tokyo, Japan.
See Also
What is Nightingale Health Oyj's Depreciation & Amortization?
Depreciation & Amortization
8.2m
EUR
Based on the financial report for Jun 30, 2024, Nightingale Health Oyj's Depreciation & Amortization amounts to 8.2m EUR.
What is Nightingale Health Oyj's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
105%
Over the last year, the Depreciation & Amortization growth was 22%. The average annual Depreciation & Amortization growth rates for Nightingale Health Oyj have been 49% over the past three years , 105% over the past five years .
You don't have any saved screeners yet
